Omeprazole and Infusion site vesicles - a phase IV clinical study of FDA data

Summary:

Infusion site vesicles is reported as a side effect among people who take Omeprazole (omeprazole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Infusion site vesicles when taking Omeprazole. It is created by eHealthMe based on reports of 400,982 people who have side effects when taking Omeprazole from the FDA, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Infusion site vesicles?

Infusion site vesicles (fluid- or air-filled cavity or sac at infusion site) is found to be associated with 85 drugs and 75 conditions by eHealthMe. Check the latest studies of Infusion site vesicles.

On Jul, 13, 2026

400,982 people reported to have side effects when taking Omeprazole.
Among them, 21 people (0.01%) have Infusion site vesicles.

Could Omeprazole cause Infusion site vesicles?

Among these 21 people:

How long have people been on Omeprazole when they have Infusion site vesicles? *

What is the gender of people who have Infusion site vesicles when taking Omeprazole? *

female: 80.95 %
male: 19.05 %

What is the age of people who have Infusion site vesicles when taking Omeprazole? *

What are other drugs people take besides Omeprazole? *

What are other side effects people have besides Infusion site vesicles? *

Infusion Site Pain: 8 people, 38.10%
Diarrhea: 6 people, 28.57%
Cardiac Disorder: 5 people, 23.81%
Infusion Site Erythema (reddening of the skin at infusion site): 5 people, 23.81%
Infusion Site Pruritus (severe itching at infusion site): 4 people, 19.05%
Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 4 people, 19.05%
Head Injury: 3 people, 14.29%
Injection Site Erythema (redness at injection site): 3 people, 14.29%
Injection Site Haematoma (localized swelling filled with blood at injection site): 3 people, 14.29%
Injection Site Induration: 3 people, 14.29%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 23.81%
Immunodeficiency Common Variable: 5 people, 23.81%
Asthma: 4 people, 19.05%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 14.29%
High Blood Pressure: 3 people, 14.29%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 14.29%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 9.52%
Pain: 2 people, 9.52%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 9.52%
Hereditary Angioedema (recurrent episodes of severe swelling): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and have Infusion site vesicles?

- Check whether Infusion site vesicles is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omeprazole:

Omeprazole (410,631 reports)

Browse all side effects of Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site vesicles:

Infusion site vesicles (85 drugs)

Browse all the conditions that are associated with Infusion site vesicles:

Infusion site vesicles (75 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.